Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy (Q60343492)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564593%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564593%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564593%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

P Price

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564593%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

N Mathiot

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564593%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

R Krueger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564593%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

S Stone

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564593%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

N M Keane

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564593%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 October 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564593%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Virology

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564593%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564593%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564593%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

279-287

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564593%20AND%20SRC:MED&resulttype=core&format=json

Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Vitreomacular traction syndrome following highly active antiretroviral therapy in AIDS patients with cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Recurrence of Mycobacterium avium infection in patients receiving highly active antiretroviral therapy and antimycobacterial agents

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Major Expansion of γδ T Lymphocytes following Cytomegalovirus Infection in Kidney Allograft Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Ancestral haplotypes: conserved population MHC haplotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Grouping HLA-B locus serologic specificities according to shared structural motifs suggests that different peptide-anchoring pockets may have contrasting influences on the course of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Exacerbation of the inflammatory response to Mycobacterium tuberculosis after antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Assessment of immune function by lymphoproliferation underestimates lymphocyte functional capacity in HIV patients treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

In vivo delayed-type hypersensitivity skin test anergy in human immunodeficiency virus type 1 infection is associated with T cell nonresponsiveness in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Altered expression of CD4, CD54, CD62L, and CCR5 in primary lymphocytes productively infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Productive infection of double-negative T cells with HIV in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Percentage of CD3+CD4-CD8-gammadeltaTCR- T cells is increased HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Cerebral mycobacterium avium infection in an HIV-infected patient following immune reconstitution and cessation of therapy for disseminated mycobacterium avium complex infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Effects of nitric oxide on the induction and differentiation of Th1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

The CC-chemokine receptor 5 (CCR5) is a marker of, but not essential for the development of human Th1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Gammadelta T cells increase with Mycobacterium avium complex infection but not with tuberculosis in AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Are MHC proteins cellular receptors for CMV?

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

High circulating levels of soluble CD30 correlate with impaired delayed-type hypersensitivity responses in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Periodontal attachment loss in HIV-infected patients is associated with the major histocompatibility complex 8.1 haplotype (HLA-A1,B8,DR3)

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

MHC haplotypes affect the expression of opportunistic infections in HIV patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

HLA antigens associated with susceptibility/resistance to HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Immune predispositions for cytomegalovirus retinitis in AIDS. The HNRC Group

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Alopecia universalis and Graves’ disease in the setting of immune restoration after highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

The significance of hypersialylation of dipeptidyl peptidase IV (CD26) in the inhibition of its activity by Tat and other cationic peptides. CD26: a subverted adhesion molecule for HIV peptide binding

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Twenty-six new polymorphic microsatellite markers around the HLA-B, -C and -E loci in the human MHC class I region

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

Mycobacteria-reactive gamma delta T cells in HIV-infected individuals: lack of V gamma 9 cell responsiveness is due to deficiency of antigen-specific CD4 T helper type 1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2801%2900200-1

7 January 2021

10.1016/S1386-6532(01)00200-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564593%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference